Vitamin C and cancer revisited
- 12 August 2008
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (32) , 11037-11038
- https://doi.org/10.1073/pnas.0806433105
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancyAnnals of Oncology, 2008
- Vitamin C Pharmacokinetics: Implications for Oral and Intravenous UseAnnals of Internal Medicine, 2004
- The Broad Spectrum of Responses to Oxidants in Proliferating Cells: A New Paradigm for Oxidative StressIUBMB Life, 1999
- High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior ChemotherapyNew England Journal of Medicine, 1985
- ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF ASCORBATE AGAINST EHRLICH ASCITES TUMOR-CELLS BY THE COPPER-GLYCYLGLYCYLHISTIDINE COMPLEX1983
- Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced CancerNew England Journal of Medicine, 1979
- Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancerProceedings of the National Academy of Sciences, 1978
- Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proceedings of the National Academy of Sciences, 1976
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974
- Ascorbic Acid and the GlycosaminoglycansOncology, 1973